EBV based cancer prevention and therapy in nasopharyngeal carcinoma
Abstract Epstein–Barr virus is an important cancer causing virus. Nasopharyngeal carcinoma is an infection-related cancer strongly driven by Epstein–Barr virus. In this cancer model, we identified the major host targets of latent membrane protein 1 which is a driving oncogene encoded by Epstein–Barr...
Main Author: | Ya Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-05-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-017-0018-x |
Similar Items
-
Genomic Landscape of EBV-associated Nasopharyngeal Carcinoma
Published: (2016) -
CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
by: Samantha Wei-Man Lun, et al.
Published: (2012-01-01) -
A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
by: Lun-Quan Sun, et al.
Published: (2010-09-01) -
Studies on EBV-specific Antibody Responses and EBV-regulated Cytokine Expression in Nasopharyngeal Carcinoma Patients
by: Yu-Tzu Huang, et al.
Published: (2001) -
The role of MSK1 in EBV reactivation in nasopharyngeal carcinoma cell
by: Dai-Rong He, et al.
Published: (2017)